Cited by — Retraction notice to “SMYD3 induces sorafenib resistance by activating SMAD2/3-mediated epithelial-mesenchymal transition in hepatocellular carcinoma” [iScience 26 (2023) 106994] | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Retraction notice to “SMYD3 induces sorafenib resistance by activating SMAD2/3-mediated epithelial-mesenchymal transition in hepatocellular carcinoma” [iScience 26 (2023) 106994].
No admitted local citation edges point to this work yet.
